Board of Management St. Molaga's National School v The Secretary General of the Department of Education and Science

Common Securitization Solutions Names Farhad Fariba Executive Vice President and Chief Technology Officer

Retrieved on: 
Monday, August 28, 2023
CSS, Uniform, Fariba, Fannie Mae, Senior, EDS, MGM Resorts International, Travel + Leisure Co., Service, Platform Invocation Services, Multimedia, McGraw Hill Education, Ally Financial, Board of Management St. Molaga's National School v The Secretary General of the Department of Education and Science, Freddie Mac, UMBS, Management, Engineering, McAfee, COMMON, HP, Common, Insurance, Trellix

BETHESDA, Md., Aug. 28, 2023 /PRNewswire/ -- Common Securitization Solutions (CSS) announced today that Farhad Fariba has joined the firm as Executive Vice President and Chief Technology Officer (CTO).

Key Points: 
  • BETHESDA, Md., Aug. 28, 2023 /PRNewswire/ -- Common Securitization Solutions (CSS) announced today that Farhad Fariba has joined the firm as Executive Vice President and Chief Technology Officer (CTO).
  • Fariba was appointed to the CSS Executive Committee by the Board of Managers and will report directly to Tony Renzi, CSS's Chief Executive Officer.
  • As CTO, Farhad will play a pivotal role in developing CSS's technology strategy while overseeing technology infrastructure, software development, cybersecurity, and emerging technologies.
  • COMMON SECURITIZATION SOLUTIONS, LLC : Common Securitization Solutions (CSS) supports U.S. housing markets as the largest and most technologically advanced mortgage securitization administrator in the financial services industry.

Bristol Myers Squibb Shares Progress Toward Its Environmental, Social, and Governance Initiatives and Its Health Equity Commitments

Retrieved on: 
Wednesday, August 23, 2023
Professional Services, Environmental, Social and Governance (ESG), Health, Research, Science, Pharmaceutical, Biotechnology, Board of Management St. Molaga's National School v The Secretary General of the Department of Education and Science, Task Force on Climate Related Financial Disclosures, Bristol Myers Squibb, Science Based Targets initiative, Disability, Clinical trial, Health equity, Electricity, Risk management, Woman, GHG, TCFD, Veteran, Targets, BMY, Fédération Aéronautique Internationale, Patient, Gold, Ethics, ESG, BMS, Developing country, Longevity, Letter, VPPA, NYSE, Pharmaceutical industry, Renewable energy, Social

As a leading biopharmaceutical company, Bristol Myers Squibb is committed to discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases.

Key Points: 
  • As a leading biopharmaceutical company, Bristol Myers Squibb is committed to discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases.
  • “At Bristol Myers Squibb, we recognize ESG’s importance to the health and longevity of our business, including how a strong ESG program can improve risk management and support long-term value creation,” said Giovanni Caforio , Chief Executive Officer, Bristol Myers Squibb.
  • Progressed its global inclusion and diversity and health equity goals: Bristol Myers Squibb awarded nearly $100 million since 2020 across 481 grants reaching over 10 million people, further progressing its commitment to $150 million by 2025.
  • Bristol Myers Squibb will be reporting Task Force on Climate Related Financial Disclosures (TCFD) for the first time later this year.

EQS-News: Dermapharm Holding SE: First half of 2023 is a success despite the challenging market environment

Retrieved on: 
Tuesday, August 22, 2023
BioNTech, Tax, Inflammation, Marketing, Pain, EUR, Dermatology, EBITDA, Board of Management St. Molaga's National School v The Secretary General of the Department of Education and Science, Parallel, Depreciation, Growth, Pharmaceutical industry

Dermapharm successfully maintains its growth trend as planned in the first six months of financial year 2023.

Key Points: 
  • Dermapharm successfully maintains its growth trend as planned in the first six months of financial year 2023.
  • "Despite a challenging market environment, our business has performed very successfully from an operational standpoint in the first half of 2023.
  • The positive performance in the first half of 2023 laid a good foundation for the further course of the business.
  • Dermapharm will publish its final figures for the first half of 2023 along with its complete 2023 half-yearly financial report on 29 August 2023.

IntelGenx Reports Second Quarter 2023 Financial Results

Retrieved on: 
Monday, August 14, 2023
Webcast, International, PD, Senior, General counsel, Corporate development, IGX, MBA, Doctor of Philosophy, Karolinska University Hospital, Board of Management St. Molaga's National School v The Secretary General of the Department of Education and Science, Administration, CDMO, Patient, Investment, CPA, Parkinson's disease, TSX, Growth, Depreciation, Research, Health Canada, Total, Cryptocurrency, Bookkeeping, Video game, Management, Pharmaceutical industry, Music, Finance, MD

SAINT LAURENT, Quebec, Aug. 14, 2023 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx") today reported financial results for the second quarter ended June 30, 2023.

Key Points: 
  • SAINT LAURENT, Quebec, Aug. 14, 2023 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx") today reported financial results for the second quarter ended June 30, 2023.
  • 2023 Second Quarter Financial Summary:
    Revenue was $133,000, compared to $398,000 in the 2022 second quarter.
  • Operating costs and expenses were $2.7 million for the second quarter of 2023, versus $2.6 million for the corresponding three-month period of 2022.
  • IntelGenx will host a conference call to discuss these second quarter 2023 financial results today at 4:30 p.m.

Indonesia's "Inspire" Receives Recognition from UNAOC-BMW Group's Intercultural Innovation Hub

Retrieved on: 
Thursday, May 25, 2023
Private sector, High, United Nations, Cultural diversity, BMW Group Plant Dingolfing, United Nations Alliance of Civilizations, Corporate social responsibility, UNAOC, People's Pledge (United States), BMW AG, Woman, Football, Women's rights, BMW, Board of Management St. Molaga's National School v The Secretary General of the Department of Education and Science, Behavior, United, Ceremony, Growth, Society, Real estate, Automotive industry, Toy, Management, Inspiration, Accenture

The support of the Intercultural Innovation Hub is a huge boost in fulfilling our vision of a more inclusive future," said Jonathan Hamilton, Founder and CEO of Inspire.

Key Points: 
  • The support of the Intercultural Innovation Hub is a huge boost in fulfilling our vision of a more inclusive future," said Jonathan Hamilton, Founder and CEO of Inspire.
  • Every year, the Intercultural Innovation Hub supports grassroots initiatives that promote intercultural dialogue and understanding, thereby contributing to peace, cultural diversity, and more inclusive societies.
  • Through the Intercultural Innovation Hub, "Inspire" will receive a financial grant, as well as one year of capacity-building and mentorship support from UNAOC, the BMW Group, and Accenture to help strengthen the "Pledge United" project and its contribution towards a more inclusive society.
  • Learn more about the project: https://interculturalinnovation.org/inspire-pledge-united/
    Milena Pighi, Head of Corporate Social Responsibility, BMW Group, [email protected]
    Copyright 2023 ACN Newswire .

EQS-News: Biotest AG: Biotest increases EBIT to Euro 19.8 million in the first half of 2023

Retrieved on: 
Thursday, August 10, 2023
Transfer, Biologics license application, Saskatchewan River Sturgeon Management Board, US Foods, Technology transfer, Grifols, Community-acquired pneumonia, S.A, Tax, Fibrinogen, EBT, Research, EBIT, Plasma, Board of Management St. Molaga's National School v The Secretary General of the Department of Education and Science, Patient, EAT, Factor, Management, Phase, FDA, III, BLA, Food, Pharmaceutical industry

The Biotest Group's total earnings after tax (EAT) increased to € 1.7 million in the first half of 2023 (same period of the previous year: € - 19.9 million) in view of the influencing factors described.

Key Points: 
  • The Biotest Group's total earnings after tax (EAT) increased to € 1.7 million in the first half of 2023 (same period of the previous year: € - 19.9 million) in view of the influencing factors described.
  • This results in earnings per ordinary share of € 0.03 after € - 0.50 in the first half of 2022.
  • Biotest develops Fibrinogen not only for congenital but also for acquired fibrinogen deficiency.
  • This increase in sales is possible due to the commissioning of the Yimmugo® production facility within Biotest Next Level.

EQS-News: INDUS Holding AG: INDUS achieves EBIT margin of 9.4% in the first half of the year

Retrieved on: 
Thursday, August 10, 2023
Semiconductor, Infrastructure, Bank statement, Tax, EBIT, Sale, Board of Management St. Molaga's National School v The Secretary General of the Department of Education and Science, EUR, Acquisition, College of Engineering (KNUST), Management, Material, Lithium, Film industry

In the Engineering segment, the portfolio companies increased their sales by 4.0% to EUR 280.7 million (previous year: EUR 269.8 million).

Key Points: 
  • In the Engineering segment, the portfolio companies increased their sales by 4.0% to EUR 280.7 million (previous year: EUR 269.8 million).
  • The segment’s operating income (EBIT) also rose by 4.4% to EUR 25.9 million (previous year: EUR 24.8 million).
  • Excluding possible impairment losses on goodwill, INDUS continues to project earnings before interest and taxes (EBIT) of between EUR 145 million and EUR 165 million.
  • The EBIT margin is expected to be at the upper end of the forecast range of 7% to 8%.

EQS-News: Leifheit Aktiengesellschaft: Growth in turnover and earnings in the first half of 2023

Retrieved on: 
Thursday, August 10, 2023
Advertising, CV, Private label, Household, Pegasus, Tax, Beiersdorf, Supervisory board, EBIT, Board of Management St. Molaga's National School v The Secretary General of the Department of Education and Science, EUR, ISIN, Management, Growth, Leifheit, Security (finance), Cryptocurrency, Retail, Renewable energy, Central Europe

The Leifheit Group generated earnings before interest and taxes (EBIT) of EUR 4.8 million (previous year: EUR 2.1 million) in the first half of 2023.

Key Points: 
  • The Leifheit Group generated earnings before interest and taxes (EBIT) of EUR 4.8 million (previous year: EUR 2.1 million) in the first half of 2023.
  • Less taxes, this equalled a net result for the period of EUR 2.6 million in the first half of 2023.
  • In the Household segment, the Leifheit Group generated turnover of EUR 115.0 million in the first half of 2023 (previous year: EUR 113.4 million), which equates to growth of 1.4%.
  • Turnover rose from EUR 8.3 million in the same period of 2022 to EUR 8.7 million in the first half of 2023.

EQS-News: INDUS Holding AG: INDUS completes reorganization of the Board of Management

Retrieved on: 
Wednesday, August 9, 2023
Engineering, Frankfurt Stock Exchange, Degenhart, ISS, West Coast of Vancouver Island Aquatic Management Board, Board of Management St. Molaga's National School v The Secretary General of the Department of Education and Science, ISS A/S, Supervisory board, CFO, Management, Knowledge, Personality, Material

Bergisch Gladbach, 9 August 2023 – The Supervisory Board of INDUS Holding AG has appointed Gudrun Degenhart as a new member of the Board of Management with effect from 1 October 2023.

Key Points: 
  • Bergisch Gladbach, 9 August 2023 – The Supervisory Board of INDUS Holding AG has appointed Gudrun Degenhart as a new member of the Board of Management with effect from 1 October 2023.
  • This concludes the reorganization of the INDUS Board of Management in line with the PARKOUR perform strategy update.
  • The Chairman of the Board of Management and the CFO are responsible for the overall management and the central functions and units of the growing group of companies.
  • “With now five Board members, INDUS is well positioned for focused growth in the highly specialized industrial technology sector,” says Chairman of the Supervisory Board Jürgen Abromeit.

EQS-News: PNE AG: Markus Lesser (CEO) reappointed to the Board of Management - CFO Jörg Klowat's term on the Board of Management to end on 31 March 2024

Retrieved on: 
Wednesday, August 9, 2023
CFO, Management, Supervisory board, PNE AG, PNE, Cuxhaven, Board of Management St. Molaga's National School v The Secretary General of the Department of Education and Science, Scale

Cuxhaven, August 9, 2023 – The Supervisory Board of PNE AG has resolved to appoint Markus Lesser, Chief Executive Officer, for a further four years until December 31, 2027, as a member of the Board of Management.

Key Points: 
  • Cuxhaven, August 9, 2023 – The Supervisory Board of PNE AG has resolved to appoint Markus Lesser, Chief Executive Officer, for a further four years until December 31, 2027, as a member of the Board of Management.
  • By mutual agreement between the Supervisory Board and Jörg Klowat (CFO), the latter will not be reappointed as CFO for PNE AG.
  • Markus Lesser was appointed to the Board of Management on May 1, 2011 after many years of activity in the renewable energy sector.
  • By joint agreement with the Supervisory Board, he was therefore not reappointed as CFO for the long term.